Vimarsana
Biggest News Aggregation in the World

Page 9 - Vida Ventures News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vida Ventures. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vida Ventures Today - Breaking & Trending Today

Breakthrough Properties Raises $3 Billion to Develop Next Generation Life Science Ecosystems - Vimarsana News

Breakthrough Properties Raises $3 Billion to Develop Next Generation Life Science Ecosystems

Breakthrough Closes Largest Ever Dedicated Life Science Real Estate Fund, Excluding Recapitalizations of Existing Portfolios Final Closing Surpass...

Breakthrough Properties Raises $3 Billion to Develop Next Generation Life Science Ecosystems - Vimarsana News

Breakthrough Properties Raises $3 Billion to Develop Next Generation Life Science Ecosystems

/PRNewswire/ -- Breakthrough Properties, a joint venture of Tishman Speyer and Bellco Capital, today announced the final closings for the Breakthrough Life...

Affini-T Therapeutics secures funding to advance T cell therapies - Vimarsana News

Affini-T Therapeutics secures funding to advance T cell therapies

Affini-T has raised $175m in an oversubscribed financing round for advancing T cell therapies for solid tumour patients with oncogenic driver mutations.

Affini-T Therapeutics Closes $175M Financing - Vimarsana News

Affini-T Therapeutics Closes $175M Financing

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations - Vimarsana News

Affini-T Therapeutics Completes $175 Million Financing Co-Led by Vida Ventures and Leaps by Bayer to Advance Groundbreaking T Cell Therapies for Solid Tumor Patients with Oncogenic Driver Mutations

Co-founded at Fred Hutchinson Cancer Research Center with Phil Greenberg, M.D., Aude Chapuis, M.D., and Tom Schmitt, Ph.D., and Vida Ventures along with serial entrepreneurs Arjun Goyal, M.D., M.Phil., and Jak Knowles, M.D./ Foundational cell therapy platform builds upon seminal work from co-founders, leveraging a T Cell Receptor (TCR) discovery en